The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry by Hemant Kulkarni, Vincent C. Marconi,

Slides:

Advertisements

Similar presentations

PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma by Paul G. Richardson,

Advertisements

Multimorbidity and risk among patients with established cardiovascular disease: a cohort study by Liam G Glynn, Brian Buckley, Donal Reddan, John Newell,

A disease risk index for patients undergoing allogeneic stem cell transplantation by Philippe Armand, Christopher J. Gibson, Corey Cutler, Vincent T. Ho,

Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.

Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi.

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? by Ching-Hon Pui, Charles G. Mullighan, William E. Evans, and Mary.

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c by Robert M. Cohen, Robert S. Franco, Paramjit K. Khera,

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation by Christopher Bredeson, Jennifer.

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma by Jonathan.

Next-generation leukemia immunotherapy

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry by Hemant Kulkarni, Vincent C. Marconi,

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

CYP4F2 genetic variant alters required warfarin dose

How I treat elderly patients with myeloma

Nonmyeloablative conditioning for relapsed follicular lymphoma

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Allogeneic Bone Marrow Transplantation for Low-Grade Lymphoma

Autologous Transplantation Therapy for Chronic Myelogenous Leukemia

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease by Sten Myrehaug, Melania Pintilie, Lingsong.

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients by William J. Hogan,

Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Solitary plasmacytoma of bone and asymptomatic multiple myeloma

Evaluation of published single nucleotide polymorphisms associated with acute GVHD by Jason W. Chien, Xinyi Cindy Zhang, Wenhong Fan, Hongwei Wang, Lue.

An actuarial GPS for hemophilic longevity

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study by Dirk.

Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell.

by James D. Cook, Carol H. Flowers, and Barry S. Skikne

by Adetola A. Kassim, Amanda B. Payne, Mark Rodeghier, Eric A

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma by Rishi K.

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma by Weiyun Z. Ai, Robert Tibshirani, Behnaz.

Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes (“pre-ATL”) in a 20-year follow-up study by Yoshitaka Imaizumi, Masako.

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types François M.J. Lamoury, Sofia Bartlett,

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma by Angela Dispenzieri,

Volume 4, Issue 1, Pages (July 2008)

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p by James I. Barnes, Vasu Divi,

CCR5-Δ32 gene deletion in HIV-1 infected patients

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia by Philip.

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.

by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E

Overall survival by SCT versus observation in first complete remission

by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A

Baseline Characteristics of the Subjects

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS by Takeshi Sugio, Kohta Miyawaki, Koji Kato, Kensuke Sasaki, Kyohei Yamada,

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma by Matthew J. Matasar, Myron S. Czuczman,

Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.

by Michael R. DeBaun, and Ellen Wright Clayton

Comparison of Baseline Characteristics by Primary End Point

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Time course analysis of the response in V1 to the M and P stimuli for a single subject. Time course analysis of the response in V1 to the M and P stimuli.

Temporal analysis of clonal evolution in typical FL and matched TFL samples. Temporal analysis of clonal evolution in typical FL and matched TFL samples.

Rituximab immunotherapy: it’s getting personal

Time-dependent survival estimation in post–polycythemia vera myelofibrosis. Time-dependent survival estimation in post–polycythemia vera myelofibrosis.

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Relationship between excess fluid, as determined by the difference between measured and estimated body water, and plasma albumin (R = −0.40, P = 0.011).

A binding relationship with thrombin

Survival of children with sickle cell disease

ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared with ibrutinib. ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared.

Cold agglutinin disease

Kaplan-Meier (K-M) curves of progression-free survival (PFS) of the entire cohort of patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier.

Presentation transcript:

The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry by Hemant Kulkarni, Vincent C. Marconi, Weijing He, Michael L. Landrum, Jason F. Okulicz, Judith Delmar, Dickran Kazandjian, John Castiblanco, Seema S. Ahuja, Edwina J. Wright, Robin A. Weiss, Robert A. Clark, Matthew J. Dolan, and Sunil K. Ahuja Blood Volume 114(13): September 24, 2009 ©2009 by American Society of Hematology

Association of low WBC counts during disease with survival in HIV-infected subjects. Hemant Kulkarni et al. Blood 2009;114: ©2009 by American Society of Hematology

WBC counts according to race/ethnicity and DARC −46C/C genotype. Hemant Kulkarni et al. Blood 2009;114: ©2009 by American Society of Hematology

Differential effects of low WBC counts on HIV disease course in HIV-infected EA and AA. KM plots depict survival curves computed according to race/ethnicity and average WBC count in the entire cohort (A), and HIV+ subjects categorized as seroconverter (B),... Hemant Kulkarni et al. Blood 2009;114: ©2009 by American Society of Hematology

Rate of HIV disease progression in HIV+ EAs, and HIV+ AAs who are Duffy-null (DARC −46C/C) or -positive (DARC −46C/T or T/T). Hemant Kulkarni et al. Blood 2009;114: ©2009 by American Society of Hematology

Relationship between decrements in the average WBC counts and the hazard ratios for time to death associated with the DARC −46C/C genotype in HIV-infected AAs. The plot represents the hazard ratios (y-axis) for rate of progression to death estimated using C... Hemant Kulkarni et al. Blood 2009;114: ©2009 by American Society of Hematology